| Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526) |
|---|
| 07/13/2011 | EP2343551A1 Disheveled PDZ modulators |
| 07/13/2011 | EP2343377A2 Proteins associated with abiotic stress response and homologs |
| 07/13/2011 | EP2343376A2 Proteins associated with abiotic stress response and homologs |
| 07/13/2011 | EP2343375A2 Proteins associated with abiotic stress response and homologs |
| 07/13/2011 | EP2343374A1 Molecules of HDV nucleic acids, fragments and applications thereof |
| 07/13/2011 | EP2343373A1 Polynucleotides and polypeptides involved in plant fiber development and methods of using same |
| 07/13/2011 | EP2343317A1 Apolipoprotein analogues |
| 07/13/2011 | EP2343316A1 Ligand binding site of RAGE and uses thereof |
| 07/13/2011 | EP2343315A2 Nucleic acid and corresponding protein named 158P1D7 useful in the treatment and detection of bladder and other cancers |
| 07/13/2011 | EP2343314A2 Calcium fluoride phosphopeptide complexes |
| 07/13/2011 | EP2343313A1 Polypeptides from non-typeable haemophilus influenzae |
| 07/13/2011 | EP2343312A1 Genes of an otitis media isolate of nontypeable haemophilus influenzae |
| 07/13/2011 | EP2343308A2 Novel immunogenic compositions for the prevention and treatment of meningococcal disease |
| 07/13/2011 | EP2343085A2 Antibody against prostate stem cell antigen (PSCA) |
| 07/13/2011 | EP2343084A1 Functional influenza virus-like particles (VLP) |
| 07/13/2011 | EP2343082A1 Oxyntomodulin for preventing or treating excess weight |
| 07/13/2011 | EP2343081A1 Interferon analogs |
| 07/13/2011 | EP2343062A1 Pharmaceuticals and methods for treating hypoxia and screening methods therefor |
| 07/13/2011 | EP2342363A1 Method for determining drug resistance mutations in any of the non-structural protein regions ns3 to ns5b of hepatitis c virus (hcv) for genotypes 1 to 6 |
| 07/13/2011 | EP2342335A1 Novel gene cluster |
| 07/13/2011 | EP2342320A1 Chinese hamster ovary cell lines |
| 07/13/2011 | EP2342225A1 Prostate stem cells and uses thereof |
| 07/13/2011 | EP2342224A2 Novel vectors for production of interferon |
| 07/13/2011 | EP2342223A2 Modified animal erythropoietin polypeptides and their uses |
| 07/13/2011 | EP2342222A1 Peptidomimetic macrocycles |
| 07/13/2011 | EP2342221A2 Methods for preparing purified polypeptide compositions |
| 07/13/2011 | EP2342220A1 Methods and systems for predicting misfolded protein epitopes |
| 07/13/2011 | EP2342218A1 Transgenic plants with increased yield |
| 07/13/2011 | EP2342217A2 Novel shigella frotein antigens and methods |
| 07/13/2011 | EP2342216A1 Sensor |
| 07/13/2011 | EP2342215A1 Methods and compositions for chlamydial antigens for diagnosis and treatment of chlamydial infection and disease |
| 07/13/2011 | EP2342214A1 Peptidomimetic macrocycles |
| 07/13/2011 | EP2341940A1 The stabilisation of proteins |
| 07/13/2011 | EP2341939A2 Dendritic cell modulatory molecule |
| 07/13/2011 | EP2341926A1 Method for purifying protein complexes |
| 07/13/2011 | EP2212347B1 Soluble gp130 muteins with improved binding activity |
| 07/13/2011 | EP2143438B1 Compositions and methods for the diagnosis and treatment of tumors |
| 07/13/2011 | EP2121935B1 Transcriptional repressors of cytokinin signaling and their use |
| 07/13/2011 | EP1999143B1 Neuromedin u receptor agonists and uses thereof |
| 07/13/2011 | EP1989939B1 Method using an oasis gene-deficient mouse |
| 07/13/2011 | EP1934245B1 Y2 selective receptor agonists for therapeutic interventions |
| 07/13/2011 | EP1860185B1 Screening method |
| 07/13/2011 | EP1812466B1 Compositions and methods for the control of mammary cell number |
| 07/13/2011 | EP1718670B1 Il-15 binding site for il 15-ralpha and specific il-15 mutants having agonist/antagonist activity |
| 07/13/2011 | EP1714976B1 Amino acid sequences from active principle of musk and their acetic salt, also the preparation and usage |
| 07/13/2011 | EP1660652B1 Amino acid-substituted coagulation factor v |
| 07/13/2011 | EP1654283B1 Improved method of purifying tfpi and tfpi analogs |
| 07/13/2011 | EP1624890B1 Identification of vaccinia virus dominant t cell epitopes |
| 07/13/2011 | EP1601775B1 Rodent model for the fast identification of pharmaceutical active compounds in vivo |
| 07/13/2011 | EP1289553B1 Nrg-2 nucleic acid molecules, polypeptides, and diagnostic and therapeutic methods |
| 07/13/2011 | EP1190043B1 Glycoprotein vi and uses thereof |
| 07/13/2011 | EP1178825B1 Adjuvant combination formulations |
| 07/13/2011 | EP0979080B1 A method of modulating an immune response in an infected mammal by transmucosal administration of modulating agent |
| 07/13/2011 | CN1922309B A respiratory syncytial virus with a genomic deficiency complemented in trans |
| 07/13/2011 | CN102124114A Method to obtain transgenic plants resistant to phytopathogen attack based on RNA interference (RNAi) |
| 07/13/2011 | CN102124029A Method of diagnosis of infection by mycobacteria and reagents therefor |
| 07/13/2011 | CN102124026A Peptides and derivatives thereof, the manufacturing thereof as well as their use for preparing a therapeutically and/or preventively active pharmaceutical composition |
| 07/13/2011 | CN102124025A Nematode-resistant transgenic plants |
| 07/13/2011 | CN102124024A Glycoprotein production method and screening method |
| 07/13/2011 | CN102123731A Immunogenic peptides derived from the midkine protein, as an anticancer vaccine |
| 07/13/2011 | CN102123606A Preparation of canola protein isolate from canola oil seeds (''blendertein'') |
| 07/13/2011 | CN102123605A Soluble canola protein isolate production from protein micellar mass |
| 07/13/2011 | CN102121017A Rice temperature sensitive male sterility gene, coding protein and application thereof |
| 07/13/2011 | CN102121015A Tea tree CsBDP an-reversible gene and application thereof |
| 07/13/2011 | CN102121014A Xenopus tropicalis interleukin 8 cDNA, cloning method and recombination application thereof |
| 07/13/2011 | CN102121012A Dog B lymphocyte activating factor cDNA, cloning method and recombination application thereof |
| 07/13/2011 | CN102121011A B lymphocyte and proliferation-inducing ligand cDNA from danio rerio, cloning method and recombinant application thereof |
| 07/13/2011 | CN102121010A Takifugu obscures B lymphocyte stimulating factor cDNA and cloning method and recombination application thereof |
| 07/13/2011 | CN102120990A New functional epitopes of human p38 alpha and TAB1 and use |
| 07/13/2011 | CN102120960A Extraction method and application of histoplasma capsulatum allergen |
| 07/13/2011 | CN102120767A Synthesis method of universal artificial antigen of alkylphenol medicines |
| 07/13/2011 | CN102120766A Preparation method and application of deoxynivalenol (DON) artificial antigen |
| 07/13/2011 | CN102120765A Method for synthetizing basic orange II artificial antigen |
| 07/13/2011 | CN102120764A Angiogenesis of triple mutant low-oxygen inducible factor 1 alpha induced by auxiliary activating factors and application thereof |
| 07/13/2011 | CN102120763A Rice osnac coding sequence and application thereof |
| 07/13/2011 | CN102120762A Arabidopsis anthocyanin pap1 purified protein and preparation method and applications thereof |
| 07/13/2011 | CN102120761A Acapsular type staphylococcus aureus extracellular polysaccharide-protein conjugate and preparation method thereof |
| 07/13/2011 | CN102120760A Antibacterial peptide derived from phage and application thereof |
| 07/13/2011 | CN102120759A Polypeptide as well as derivatives and application thereof |
| 07/13/2011 | CN101569749B preparation method of dextran-hemoglobin conjugate as potential blood substitute |
| 07/13/2011 | CN101133076B Synthesis using peptide intermediate fragments |
| 07/13/2011 | CN101113169B Use of sorting protein SNX10 for suppressing growth of tumour cell |
| 07/12/2011 | US7977468 Chromosome 3p21.3 genes are tumor suppressors |
| 07/12/2011 | US7977459 Adiponectin receptor and gene encoding the same |
| 07/12/2011 | US7977458 Modified chaperonin 10 |
| 07/12/2011 | US7977457 Fusion proteins, uses thereof and processes for producing same |
| 07/12/2011 | US7977455 Analogues of GLP-1 |
| 07/12/2011 | US7977317 Compositions and methods for modulating blood-brain barrier transport |
| 07/12/2011 | US7977312 TGF- beta binding proteins which can be utilized to increase bone mineralization, and thus may be utilized in treating osteopenia, osteoporosis and bone fractures |
| 07/12/2011 | US7977311 Methods and compositions for the prevention and treatment of anemia |
| 07/12/2011 | US7977309 Methods of using motilin homologs |
| 07/12/2011 | US7977307 Method for reducing pain with ziconotide and morphine |
| 07/12/2011 | US7977306 Albumin fusion proteins |
| 07/12/2011 | US7977119 Chemical arrays and methods of using the same |
| 07/12/2011 | US7977118 Two helix binders |
| 07/12/2011 | US7977091 Eukaryotic layered vector initiation systems |
| 07/12/2011 | US7977087 Detection instrument with the use of polynucleotides mapped on barley chromosome |
| 07/12/2011 | US7977077 Synthesis of intermediates of oseltamivir carboxylates |
| 07/12/2011 | US7977071 Binding moieties based on shark ignar domains |
| 07/12/2011 | US7977069 DNA encoding a CCK-8S G-protein coupled receptor, and vectors, transformants, cell kits, and methods employing such DNA |